Duplications in the~2 Mb desert region upstream of SOX9 at 17q24.3 may result in familial 46,XX disorders of sex development (DSD) without any effects on the XY background. A balanced translocation with its breakpoint falling within the same region has also been described in one XX DSD subject. We analyzed, by conventional and molecular cytogenetics, 19 novel SRY-negative unrelated 46,XX subjects both familial and sporadic, with isolated DSD. One of them had a de novo reciprocal t(11;17) translocation. Two cases carried partially overlapping 17q24.3 duplications~500 kb upstream of SOX9, both inherited from their normal fathers. Breakpoints cloning showed that both duplications were in tandem, whereas the 17q in the reciprocal translocation was broken at~800 kb upstream of SOX9, which is not only close to a previously described 46,XX DSD translocation, but also to translocations without any effects on the gonadal development. A further XX male, ascertained because of intellectual disability, carried a de novo cryptic duplication at Xq27.1, involving SOX3. CNVs involving SOX3 or its flanking regions have been reported in four XX DSD subjects. Collectively in our cohort of 19 novel cases of SRY-negative 46,XX DSD, the duplications upstream of SOX9 account for~10.5% of the cases, and are responsible for the disease phenotype, even when inherited from a normal father. Translocations interrupting this region may also affect the gonadal development, possibly depending on the chromatin context of the recipient chromosome. SOX3 duplications may substitute SRY in some XX subjects. European Journal of Human Genetics (2015) 23, 1025-1032; doi:10.1038/ejhg.2014.237; published online 5 November 2014 INTRODUCTION 46,XX disorders of sex development (DSDs) are congenital conditions in which, in the presence of a female karyotype, the development of gonadal and anatomical sex is atypical, ranging from various degrees of ambiguous genitalia to phenotypic males with azoospermia. These conditions are poorly characterized, at least in subjects whose DNA does not contain SRY, the gene triggering testis differentiation in mammals. 1 In fact, in most XX males, SRY is transposed to the tip of Xp as a consequence of a recurrent Xp;Yp translocation, arising predominantly by nonallelic homologous recombination between PRKX and PRKY on a particular Y haplotypic background. 2,3 These males, usually with small testes, are essentially picked up among men with nonobstructive azoospermia.
INTRODUCTION
46,XX disorders of sex development (DSDs) are congenital conditions in which, in the presence of a female karyotype, the development of gonadal and anatomical sex is atypical, ranging from various degrees of ambiguous genitalia to phenotypic males with azoospermia. These conditions are poorly characterized, at least in subjects whose DNA does not contain SRY, the gene triggering testis differentiation in mammals. 1 In fact, in most XX males, SRY is transposed to the tip of Xp as a consequence of a recurrent Xp;Yp translocation, arising predominantly by nonallelic homologous recombination between PRKX and PRKY on a particular Y haplotypic background. 2, 3 These males, usually with small testes, are essentially picked up among men with nonobstructive azoospermia.
A much less well-understood category is that of the 46,XX DSDs negative for SRY. Recently, six of these cases have been reported carrying partially overlapping amplifications of a gene-desert region located~500 kb upstream of SOX9. [4] [5] [6] [7] It has been proposed that these CNVs could be responsible for altered expression of SOX9 in the developing gonad on an XX background. Some of the reported cases represent familial 46,XX DSDs, as normal and fully fertile XY fathers can carry this CNV.
In the XY early gonad, after initial activation by SRY, SOX9 maintains its expression thanks to a positive feedback loop triggering the pathway of testis differentiation. 8 Actually, SOX9 transgenic expression in XX gonads is sufficient to induce testis formation in mice. 9 Moreover, a single case of an XX boy is reported with a 411 Mb duplication, including SOX9. 10 SOX9 is also involved in several processes during the embryo development, and defects of this gene are responsible for campomelic dysplasia with/without XY sex reversal (OMIM:114290). This gene has a large upstream desert region of~2 Mb enriched in tissue-and time-specific regulatory elements, as it can be deduced by different abnormal phenotypes associated with CNVs or reciprocal translocations, interrupting the region itself. Among them, isolated Pierre Robin sequence (PRS) (OMIM:261800), congenital heart defects, and XY sex reversal have been associated mainly with deletions of the region, and in few cases with reciprocal translocations, 4,11-13 whereas duplications have been reported both in familial cases of brachydactyly-anonychia 14 and in the abovementioned XX subjects with DSD. In the latter category, a single case with a reciprocal translocation, interrupting the desert region~800 kb upstream of SOX9, has also been described. 15 Recently, a role in the developing gonad has also been proposed for SOX3 (Sry-related HMG box-containing gene 3), a gene closely related to both SOX9 and SRY. Ectopic expression of Sox3 in the mouse bipotential gonad frequently leads to complete XX sex reversal. 16 Moreover, duplications of SOX3 or its 5′ region have been reported in 46,XX DSD patients. 16, 17 Here, we present two new subjects with cryptic duplications upstream of SOX9 that were identified among 19 unrelated novel cases with 46,XX isolated DSDs, either familial (2 cases) or sporadic (17 cases), all SRY-negative. In the same cohort, we also identified the second case of reciprocal translocation upstream of SOX9, causing XX DSD. A further 46,XX boy with intellectual disability (ID) and a cryptic duplication, including SOX3, is also presented.
Our data confirm that CNVs and structural rearrangements (cases 1-3) involving desert regions are responsible for the developmental defects by dysregulation of non-coding cis-regulatory elements, 18 and that 46,XX SRY-negative DSD individuals present a duplication upstream of SOX9 in at least 10.5% of cases. The role of CNVs in gonadal disorders is further stressed by case 20.
SUBJECTS AND METHODS

Patient samples
Patients were collected during 420 years. The study was approved by the Ethical Committee of the University of Pavia. Written informed consent was obtained from all patients.
Conventional and molecular cytogenetics
Conventional cytogenetics was done on GTG-banded metaphases. Molecular karyotyping was performed for cases 1-3 and for all cases reported in Supplementary Table 1 by using oligonucleotide array-CGH platforms (180 K SurePrint G3 Human Kit, Agilent Technologies, Santa Clara, CA, USA). For case 20, the trio analysis was performed using the Genome Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA). For details, see Supplementary Material. FISH experiments were performed on case 3, as reported, 19 by using the following probes: RP11-238F2, RP11-589A10, CTD-2652P12, RP11-879D6, RP11-474K15, RP11-676K3, RP11-13H17, RP11-661B15, RP11-103P20, RP11-36H11. SRY analysis was done as reported in Supplementary Material.
The observed CNVs have been submitted to the public database DECIPHER (http://decipher.sanger.ac.uk; IDs from case 1-case 20: 293610, 293615, 293631, 293646).
X-inactivation analysis
X-inactivation analysis was performed for case 20 according to Allen et al. 20 
Breakpoint mapping
For cases 1 and 2, we used quantitative PCR (qPCR) to verify and restrict the breakpoint regions characterized by array-CGH, followed by long-range PCR. 21 To clone case 3 breakpoint junctions, we used pooled long-range PCR reactions (for details, see Supplementary Material). Target sequences for qPCR analysis were selected using the Primer Express 3.0 software (Applied Biosystems, Foster City, CA, USA). Long-range PCRs were performed with JumpStart Red ACCUTaq LA DNA polymerase (Sigma-Aldrich, St Louis, MO, USA). PCR products were analyzed on 0.8% agarose TAE gels. The UCSC Genome Browser (hg19 assembly) maps and sequence were used as reference. Sequencing reactions were performed with a Big Dye Terminator Cycle Sequencing kit (Applied Biosystems) and run on an ABI Prism 3500DX/XL Genetic Analyzer.
In silico TFBSs evaluation
For case 3, the presence of potential transcription factor-binding sites (TFBSs) altered by the translocation breakpoints was evaluated by using the TFSEARCH tool (http://www.rwcp.or.jp/papia/). 22 In cases 1-3, the region involved by the rearrangement was also evaluated in the light of integrated regulation from ENCODE, HMR-conserved TFBSs and human body map lincRNAs, and TUCP transcripts tracks embedded in the UCSC genome browser (http://genome.ucsc. edu/).
RESULTS
Clinical description
Case 1. The patient, a normal adult male, was investigated because of infertility. Physical examination showed normal male secondary sexual characteristics and bilateral gynecomastia. Laboratory investigations showed azoospermia, low serum testosterone, and increased FSH and LH.
Case 2. The patient was born at term after two normal female children from nonconsanguineous parents. A threatened abortion in the first trimester is documented. External genitalia were ambiguous with hypertrophic clitoris, single meatus, and urogenital sinus. Ecography showed absent uterus, vaginal atresia, and two ovoidal gonads detected in the inguinal canal. At 8 months of age, hormonal values were as the following: LH was below 0.1 mU/ml (normal range o0.1-6 mU/ml), FSH was 0.8 mU/ml (normal range o0.1-18 mU/ml), testosterone was below 10 ng/dl (normal ranges: 12-21 ng/dl males, 6-82 ng/dl females), androstenedione was below 30 ng/dl (normal range 40-260 ng/dl), estradiol was below 25 pg/ml (normal values o25 pg/ml), anti-Müllerian hormone was above 21 ng/ml (normal ranges: 84-141 ng/ml males,o0.14 ng/ml females). The testosterone response to human chorionic gonadotropin (hHCG) administration was low: 76 ng/dl (normal values 4100 ng/dl). After hHCG stimulation, the left gonad showed the presence of follicles and assumed the aspect of an ovotestis at echography, whereas the right one appeared as a testicle. Bilateral gonadal biopsy was performed at 1 year of age. Both gonads were presented with the caudal portions macroscopically compatible with male gonads and the cranial ones with female gonads. At histological examination, the caudal segments showed testicular tissue with prepubertal seminiferous tubules, whereas the cranial ones showed ovarian tissue with numerous oocytes (Supplementary Figure 1) . Case 3. The patient was ascertained in adult age because of infertility. His height was 171 cm, between the 10th and the 25th centile, much shorter than expected on the basis of the mid-parental height (183 cm). He presented with infertility and erectile dysfunction, loss of libido, and asthenia. On general examination, the patient had mild dysmorphisms, such as micrognathia, hypertelorism, short neck. He had bilateral testicular hypotrophy, normal penis, and absence of gynecomastia. FSH (53.3 mU/ml, normal values 0.7-11.1) as well as LH (19.4 mU/ml, normal values 0.8-8.0) and androstenedione (13.1 nmol/l, normal values 2.1-10.8) levels were elevated, whereas he had low serum testosterone (210 ng/dl, normal values 260-1600). The patient also suffered from osteopenia.
Cases 4-19. These cases, all with normal 46,XX karyotype and SRYnegative, were ascertained because of ambiguous genitalia, or hypogonadism, or azoospermia. In all of them, genomic arrays did not show any significant CNV. Their clinical details are summarized in Supplementary Table 1 . Some of them, previously published, have now been tested by array-CGH.
Case 20. The patient was ascertained at 8 years of age because of mild developmental and language delay. He was born at term from nonconsanguineous parents, after an uncomplicated pregnancy. At birth, he weighed 3240 g (75th centile) and his length and head circumference were 49 cm (50th centile) and 35 cm (50-75th centile), respectively. He started walking and talking after 2 years of age. No facial or skeletal abnormalities were identified by physical examination, and he had normal male genitalia. The parents reported sleep disturbances with some episodes of pavor nocturnus.
Molecular cytogenetic investigations
For all the reported cases, except for case 3, a normal 46,XX karyotype was identified by conventional cytogenetics. The presence of SRY was ruled out in all patients by PCR or FISH analysis. Genome-wide copy number analysis was performed by CGH-or SNP-arrays for all reported patients. The results for cases 1-3 and 20 together with their clinical data are summarized in Table 1 . In cases 1 and 2, array-CGH analysis identified partially overlapping 17q24.3 duplications of different sizes, involving the gene-desert region upstream of SOX9 (Figure 1a ). For both cases, the duplication was also present in paternal DNA. Both sisters of case 2 did not show the RevSex duplication.
The breakpoints of the duplications were finely mapped and cloned for both cases, (Figure 1b) and were located at 69 513 605 bps (proximally) and 69 692 812 bps (distally) for case 1 and at 69 404 081 bps (proximally) and 69 872 909 bps (distally) for case 2 (hg19), respectively. Three of the breakpoints occurred within regions of long interspersed nuclear elements, but there is no homology between the breakpoint sequences. Junction sequencing demonstrated that both duplications are direct. Case 1 junction shows insertion of four additional bases, probably derived by the duplication of adjacent sequence. Case 2 junction has a one-base overlap.
In case 3, karyotype analysis revealed the presence of a 46,XX karyotype with a de novo reciprocal translocation t(11;17)(p13;q24.3). Array-CGH analysis did not detect any imbalance but common CNVs, whereas FISH analysis allowed narrowing the breakpoints on the two derivative chromosomes. The BAC probe RP11-661B15 encompassed the breakpoint on chromosome 11, and the two BAC probes, CTD-2652P12 and RP11-879D6, encompassed the one on chromosome 17 (Figures 2a-b) . Breakpoint mapping was performed by multiple long-range PCR reactions and sequencing, allowing to locate them at 35 935 981 bp on chromosome 11 and between 69 187 829 and 69 187 844 bp on chromosome 17, with a loss of 15 bp (Figure 2c) . The rearrangement did not create or abrogate any predicted TFBS.
Cases 4-19 did not show any significant CNV (Supplementary Table 1) .
Case 20 showed a 46,XX karyotype. SNP-array analysis detected the presence of a 5.6 Mb duplication of the long arm of a chromosome X, involving the SOX3 gene ( Figure 1c) ; the duplication was de novo and had occurred on the paternal allele. X-inactivation analysis showed a random pattern of inactivation.
DISCUSSION
We present 19 unrelated cases of 46,XX subjects, with isolated abnormal gonadal development and male or ambiguous genitalia, all in the absence of the SRY gene. A further 46,XX SRY-negative subject showed syndromic DSD. A genomic imbalance or a chromosome rearrangement was detected in four. In three of them (cases 1, 3, and 20), external genitalia were unquestionably male with testes, whereas in one case (case 2) they were ambiguous with ovotestes.
Duplications of the desert region upstream of SOX9 Cases 1 and 2, an infertile male and a child with ovotestes, had partially overlapping duplications covering the so-called RevSex critical region on chromosome 17q24; such duplications have already been associated with 46,XX DSDs. [4] [5] [6] [7] Our cases do not further narrow the minimal duplicated interval reported so far (Figure 3 ), but demonstrate that this genomic alteration is not rare among SRY-negative XX Testis development in the absence of SRY A Vetro et al Testis development in the absence of SRY A Vetro et al males and further establish that the duplication can be inherited by a healthy and fertile father. Although the frequency of genomic alterations involving the SOX9-coding region in 46,XX testicular or ovotesticular DSDs has been questioned, 23 we identified copy number gains upstream of this gene in 2 of 19 novel cases with isolated 46,XX DSDs negative for SRY, either sporadic or familial, accounting for the 10.5% of our cohort. Considering that we have previously detected two further cases owing to the same cohort with similar RevSex duplications (Vetro et al, 6 and a family that did not give consent to the publication), we may conclude that this frequency is even higher. In both our cases 1 and 2, the same duplication was present in the proband's father, as for some previously reported cases, suggesting that a copy gain of the region does not affect sex development and fertility in 46,XY subjects, where SOX9 transcription is anyway activated during gonadal development. In a 46,XX background, in contrast, the presence of the duplication could be responsible of inappropriate expression of SOX9 in the embryo gonadal ridge.
Hypothetical mechanisms explaining the association between copy number gains at 17q24 and XX DSD are the following:
1. The duplication could alter SOX9 expression by increasing the dosage of one or more gonadal-specific enhancers located within the minimal duplicated interval defined as RevSex. This hypothesis is supported by the finding that deletions and duplications of the RevSex region have mirror effects, the firsts being associated with sex reversal in XY but not in XX subjects, 4, 24 and the latter with XX sex reversal but no effect in XY individuals, as shown by familial cases [4] [5] [6] (Figure 3) . Therefore RevSex appears to be dosage sensitive although noteworthy exceptions, namely a duplication in one fertile XX female 4 and a deletion in a fertile XY male, 25 suggest that SOX9 dysregulation can, in some cases, be leaky possibly due to genomics modifier(s) of gonadal differentiation.
The minimal overlapping region of RevSex CNVs is~70 kb (chr17:69 534 400-69 600 000, hg19). To explain why larger duplications containing RevSex are associated with brachydactyly-anonychia but not with sex reversal (dark green in Figure 3) , we hypothesize that the additional copy of the critical region is placed too far from SOX9 to be able to influence its expression in the gonads.
2. An alternative model might consider that the amplifications abrogate SOX9 silencing by moving a hypothetical negative regulatory Testis development in the absence of SRY A Vetro et al element located upstream of RevSex (negative gonadal regulatory element (NGRE), dashed blue line in Figure 3 ), too far away to exert any influence on SOX9 promoter. In fact, SOX9 repression needs to be maintained on the XX background both in the developing gonad 26 and in the ovary, 27 in order to ensure the differentiation and maintenance of ovarian cell fate. NGRE would not be displaced, but rather included in duplications associated with brachydactylyanonychia but not with sex reversal (dark green in Figure 3 ). However according to this hypothesis, also proposed by Xiao et al, 7 haploinsufficiency of such NGRE element should lead to the gonadal overexpression of SOX9, thus resulting in XX sex reversal. In contrast, a number of deletions, none of them associated with XX DSD, have been reported, covering the entire region delimited by the centromeric end of the RevSex duplications and the KCNJ2 gene. These individuals, either XX or XY, were investigated because of Pierre-Robin syndrome or cardiac defects. 11, 13, 28, 29 The two duplications that we described are both in tandem, as reported for other DSD cases, 4,5 but a specific predisposing genomic architecture has not been highlighted. This duplication, although without effect in the XY background, appears to be very rare, with no cases containing at least the minimal duplicated RevSex region among the 14 316 individuals collected in the Database of Genomic Variants. 30 This is in agreement with the extreme rarity of the SRYnegative 46,XX DSD condition.
Interruption of the desert region upstream of SOX9
We also report the second case of a balanced translocation associated with XX sex reversal (case 3). Breakpoint mapping allowed us to precisely define the 17q breakpoint of the t(11;17) translocation, which is located~115 kb upstream of that reported by Refai et al 15 The existence of a single gonadal-specific regulatory element interrupted by both these translocations is contradicted by the presence of translocation breakpoints in the same interval in at least three unrelated 46,XX females with normal sexual development (light green in Figure 3 ). [31] [32] [33] As suggested, 31 the chromatin environment of the recipient region may alter SOX9 regulation, even though in all these cases RevSex is translocated to the derivative chromosome together with SOX9, thus, in theory, retaining the cis-regulatory elements necessary for its gonadal expression. Our patient 3 also shows signs of PRS. Several deletions and translocations, mapping in the region from 585 kb to 1.8 Mb upstream of SOX9, have been reported in patients with isolated PRS. 11, 29, 31, 32, 34 These cases point to the existence of SOX9-regulatory elements, driving the expression of this gene in craniofacial structures, although no single element specifically impaired by the reported rearrangements has been yet identified.
SOX3 duplication
Finally, we report a new case of SOX3 duplication in a 46,XX boy ascertained because of mild developmental delay (case 20). SOX3, encoding a protein very similar to SRY, might be the ancestral SOX gene from which the SRY gene was derived. 35 Duplications involving SOX3 and deletions of its 5′ region (Figure 1d ) have been reported in at least four cases of XX DSD. 16, 17 Moreover, a mouse model in which SOX3 is ectopically expressed in the developing gonads shows complete XX sex reversal, suggesting that gain-of-function mutations of SOX3 might act as an SRY surrogate in sex determination, promoting SOX9 gonadal expression. 16 Interestingly, SOX3 duplications have been reported in two unrelated 46,XY individuals with X-linked hypopituitarism, whereas their carrier mothers were unaffected. 36, 37 No hypopituitarism was present in our case 20 or in the patient reported by Moalem et al. 17 An X-linked dominant but leaky mutation affecting sex development in a portion of XX subjects might be hypothesized, either as a consequence of the X-inactivation pattern in the developing gonad or of specific genomic modifiers.
CONCLUSIONS
We report additional evidences suggesting that, in the absence of SRY, altered expression of genes crucial to gonadal development, such as SOX9 and SOX3, may invert the expected embryonic plan.
Whereas for SOX3, it is easier to envisage a direct link between its duplication and increased gene expression, 16 it is more difficult to understand the true functional link between duplications upstream of SOX9 and the different abnormal phenotypes, including gonadal abnormal differentiation.
Our study reports that the incidence for RevSex copy number gains associated with SRY-negative isolated 46,XX DSDs is 410%.
We can speculate that the RevSex duplication causes increased expression of SOX9 in undifferentiated gonadal cells, thus, resulting in testis differentiation even in the absence of SRY. In fact, duplications of SOX9 are associated with XX sex reversal not only in transgenic mice 9 but also in the recently reported case of a deer, 38 and in three cases of dogs. 39 Our case 3 shows that also interruption of the region upstream to the RevSex can result in XX sex reversal. Altogether our data reinforce the role of the desert region upstream of SOX9 in the regulation of this gene, as indicated by an altered histone methylation signature demonstrated in one of the RevSex duplicated cases. 40 It is noteworthy that RevSex includes two lncRNAs, TCONS_00025195 and TCONS_00025196, with specific expression in the testis, 41 possibly having a role in SOX9 transcriptional regulation.
